Fleqsuvy FDA Approval History
Fleqsuvy (baclofen) is an oral suspension formulation of baclofen for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
Development timeline for Fleqsuvy
|Feb 7, 2022||Approval FDA Approves Fleqsuvy (baclofen oral suspension) for the Treatment of Spasticity|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.